![]() | |||
While the coronavirus has dominated the field of infectiology since the start of the pandemic, this year’s ECCMID congress regains more diversity: Covid-19 is still an obvious mainstay, but management of antibiotic resistance and regulatory issues such as the upcoming IVDR make a return for the first hybrid edition of the event. Enjoy reading! |
|||
![]() |
|||
Article • Drug dose optimisationAntibiotics: no more ‘dosing in the dark’Finding the right antibiotic dose is akin to a Goldilocks problem: give too little, and the infection will persist; too much, and side-effects will override the benefits of the therapy. To get it “just right”, Prof Dr Birgit Koch talks about ... |
|||
|
|||
|
|||
|
|||
|
|||
|
|||
|
|||
Collections |
|||
|
|||
|